SEC 13F Intelligence

Rtw Investments, LP / SG7

Rtw Investments, LP’s Sage Therapeutics Inc Position

Does Rtw Investments, LP own Sage Therapeutics Inc (SG7)? Not currently — the last reported position was 3.00M shares worth $16M in Q4 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$16M
Q4 2024
Shares
3.00M
% of Portfolio
+0.25%
Quarters Held
7
position exited

Position History SG7

Reported value by quarter
Q4 ’18: $16MQ4 ’18Q3 ’23: $106MQ3 ’23Q4 ’23: $113MQ4 ’23Q1 ’24: $103MQ1 ’24Q2 ’24: $60MQ2 ’24Q3 ’24: $40MQ3 ’24Q4 ’24: $16MQ4 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q4 20243.00M$16M+0.25%
Q3 20245.59M$40M+0.58%
Q2 20245.48M$60M+0.92%
Q1 20245.48M$103M+1.52%
Q4 20235.20M$113M+1.76%
Q3 20235.15M$106M+2.24%
Q4 2018166.0K$16M+1.46%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rtw Investments, LP’s full portfolio or all institutional holders of SG7.